Celldex Therapeutics Presents Positive 12 Week Results from

- Primary and secondary endpoints met with clinically meaningful and statistically significant decreases in urticaria disease activity across multiple dose...

Related Keywords

United States ,Berlin ,Germany ,American ,Anthonys Marucci ,Marcus Maurer ,Sarah Cavanaugh ,Allen Kaplan ,Nasdaq ,American Academy Of Allergy ,Corporate Affairs Administration ,Company Phase ,Company Contact ,Celldex Therapeutics Inc ,Celldex Therapeutics ,American Academy ,Annual Meeting ,Chief Executive Officer ,Clinical Activity Assessments ,Confidence Interval ,Complete Control ,Private Securities Litigation Reform Act ,Vice President ,Corporate Affairs ,Nasdaq Cldx ,Nc ,